nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—AGTR1—blood plasma—schizophrenia	0.0211	0.19	CbGeAlD
Eprosartan—CYP2C9—urine—schizophrenia	0.0195	0.175	CbGeAlD
Eprosartan—Losartan—ACE—schizophrenia	0.0192	0.476	CrCbGaD
Eprosartan—Losartan—CYP1A2—schizophrenia	0.0136	0.338	CrCbGaD
Eprosartan—AGTR1—forebrain—schizophrenia	0.0116	0.104	CbGeAlD
Eprosartan—CYP2C9—blood plasma—schizophrenia	0.0102	0.0914	CbGeAlD
Eprosartan—AGTR1—blood—schizophrenia	0.00773	0.0695	CbGeAlD
Eprosartan—Losartan—ABCB1—schizophrenia	0.00749	0.186	CrCbGaD
Eprosartan—AGTR1—endocrine gland—schizophrenia	0.0067	0.0603	CbGeAlD
Eprosartan—AGTR1—nervous system—schizophrenia	0.00627	0.0564	CbGeAlD
Eprosartan—AGTR1—central nervous system—schizophrenia	0.00604	0.0543	CbGeAlD
Eprosartan—ABCC2—blood—schizophrenia	0.00559	0.0502	CbGeAlD
Eprosartan—ABCC2—endocrine gland—schizophrenia	0.00484	0.0436	CbGeAlD
Eprosartan—AGTR1—brain—schizophrenia	0.00479	0.0431	CbGeAlD
Eprosartan—CYP2C9—blood—schizophrenia	0.00372	0.0335	CbGeAlD
Eprosartan—CYP2C9—endocrine gland—schizophrenia	0.00323	0.029	CbGeAlD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.00319	0.00376	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CHRM1—schizophrenia	0.00318	0.00374	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A4—schizophrenia	0.00317	0.00374	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—schizophrenia	0.00316	0.00373	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00312	0.00368	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00308	0.00363	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DGKI—schizophrenia	0.00305	0.00359	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00303	0.00357	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—schizophrenia	0.00302	0.00356	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00297	0.0035	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00297	0.0035	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—CYP1A2—schizophrenia	0.00297	0.0035	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GRM5—schizophrenia	0.00295	0.00348	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.00292	0.00344	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.0029	0.00341	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00286	0.00337	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HSPA1A—schizophrenia	0.00285	0.00336	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00284	0.00335	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A3—schizophrenia	0.00283	0.00333	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00282	0.00333	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00282	0.00333	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00282	0.00332	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.0028	0.0033	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DGKI—schizophrenia	0.00277	0.00326	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00276	0.00326	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00276	0.00326	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCK—schizophrenia	0.0027	0.00318	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00268	0.00315	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.0026	0.00306	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCKAR—schizophrenia	0.00259	0.00305	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00257	0.00303	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00256	0.00302	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.00253	0.00299	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00253	0.00298	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADORA2A—schizophrenia	0.00251	0.00296	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00248	0.00292	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TAAR6—schizophrenia	0.00243	0.00287	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GRM2—schizophrenia	0.00243	0.00287	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00242	0.00285	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00242	0.00285	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GSTP1—schizophrenia	0.00239	0.00282	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—schizophrenia	0.00235	0.00277	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—FZD3—schizophrenia	0.00235	0.00277	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPY—schizophrenia	0.00235	0.00276	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.0023	0.00271	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00229	0.0027	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.00228	0.00268	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP26B1—schizophrenia	0.00226	0.00267	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR1B—schizophrenia	0.00226	0.00267	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OXT—schizophrenia	0.00226	0.00267	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NGEF—schizophrenia	0.00225	0.00265	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP26B1—schizophrenia	0.00223	0.00263	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.00221	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP3CC—schizophrenia	0.00221	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM2—schizophrenia	0.00221	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TAAR6—schizophrenia	0.00221	0.00261	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NTS—schizophrenia	0.0022	0.00259	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GSTM1—schizophrenia	0.0022	0.00259	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—schizophrenia	0.00219	0.00258	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR1A—schizophrenia	0.00218	0.00257	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—NRG1—schizophrenia	0.00216	0.00255	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPS—schizophrenia	0.00215	0.00253	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2C—schizophrenia	0.0021	0.00248	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD1—schizophrenia	0.0021	0.00248	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00208	0.00245	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GRM3—schizophrenia	0.00207	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RGS4—schizophrenia	0.00207	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NGEF—schizophrenia	0.00205	0.00241	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD3—schizophrenia	0.00204	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR6—schizophrenia	0.00203	0.00239	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GCLM—schizophrenia	0.00202	0.00238	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NTS—schizophrenia	0.002	0.00236	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00198	0.00233	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD4—schizophrenia	0.00198	0.00233	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.00197	0.00233	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CNR1—schizophrenia	0.00189	0.00223	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RGS4—schizophrenia	0.00188	0.00222	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM3—schizophrenia	0.00188	0.00222	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR6—schizophrenia	0.00185	0.00217	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR7—schizophrenia	0.00184	0.00217	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD2—schizophrenia	0.00184	0.00217	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.00181	0.00213	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CHRM1—schizophrenia	0.0018	0.00212	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL3RA—schizophrenia	0.00175	0.00206	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.00173	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.0017	0.002	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GRM5—schizophrenia	0.00167	0.00197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DGKI—schizophrenia	0.00163	0.00193	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CHRM1—schizophrenia	0.00163	0.00192	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.0016	0.00189	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL3RA—schizophrenia	0.00159	0.00187	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCK—schizophrenia	0.00153	0.0018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM5—schizophrenia	0.00152	0.00179	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP1R1B—schizophrenia	0.00149	0.00176	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4B—schizophrenia	0.00149	0.00175	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCKAR—schizophrenia	0.00146	0.00172	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADORA2A—schizophrenia	0.00142	0.00167	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FZD3—schizophrenia	0.00139	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCK—schizophrenia	0.00139	0.00163	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.00138	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4B—schizophrenia	0.00135	0.00159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCKAR—schizophrenia	0.00133	0.00157	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPY—schizophrenia	0.00133	0.00156	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP3CC—schizophrenia	0.00131	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FES—schizophrenia	0.00131	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM2—schizophrenia	0.00131	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TAAR6—schizophrenia	0.00131	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—schizophrenia	0.00129	0.00152	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADORA2A—schizophrenia	0.00129	0.00152	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OXT—schizophrenia	0.00128	0.00151	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1B—schizophrenia	0.00128	0.00151	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—schizophrenia	0.00127	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1A—schizophrenia	0.00123	0.00145	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2D6—schizophrenia	0.00122	0.00144	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPS—schizophrenia	0.00121	0.00143	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGEF—schizophrenia	0.00121	0.00142	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2D6—schizophrenia	0.00121	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPY—schizophrenia	0.0012	0.00142	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.0012	0.00142	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.0012	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD1—schizophrenia	0.00119	0.0014	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2C—schizophrenia	0.00119	0.0014	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTS—schizophrenia	0.00118	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OXT—schizophrenia	0.00116	0.00137	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1B—schizophrenia	0.00116	0.00137	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD3—schizophrenia	0.00115	0.00136	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP2A2—schizophrenia	0.00113	0.00134	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1A—schizophrenia	0.00112	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD4—schizophrenia	0.00112	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM3—schizophrenia	0.00111	0.00131	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RGS4—schizophrenia	0.00111	0.00131	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RTN4—schizophrenia	0.00111	0.00131	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP1A2—schizophrenia	0.00111	0.0013	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPS—schizophrenia	0.0011	0.0013	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP1A2—schizophrenia	0.00109	0.00129	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR6—schizophrenia	0.00109	0.00128	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD1—schizophrenia	0.00108	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2C—schizophrenia	0.00108	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CNR1—schizophrenia	0.00107	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAG—schizophrenia	0.00105	0.00124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD3—schizophrenia	0.00105	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR7—schizophrenia	0.00104	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD2—schizophrenia	0.00104	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD4—schizophrenia	0.00102	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CNR1—schizophrenia	0.000969	0.00114	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CHRM1—schizophrenia	0.000963	0.00113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.000962	0.00113	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD2—schizophrenia	0.000946	0.00111	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR7—schizophrenia	0.000946	0.00111	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL3RA—schizophrenia	0.000938	0.00111	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—COMT—schizophrenia	0.000927	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTP1—schizophrenia	0.000923	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAOA—schizophrenia	0.00092	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRG3—schizophrenia	0.000916	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TLE1—schizophrenia	0.000916	0.00108	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—COMT—schizophrenia	0.000914	0.00108	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTP1—schizophrenia	0.00091	0.00107	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	0.000906	0.00107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GFAP—schizophrenia	0.000905	0.00107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM5—schizophrenia	0.000895	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TLE3—schizophrenia	0.000867	0.00102	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTM1—schizophrenia	0.000848	0.000999	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM1—schizophrenia	0.000836	0.000985	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCK—schizophrenia	0.000819	0.000965	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE4B—schizophrenia	0.000798	0.00094	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRODH—schizophrenia	0.000793	0.000935	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCKAR—schizophrenia	0.000785	0.000925	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADORA2A—schizophrenia	0.000761	0.000897	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000748	0.000882	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGA—schizophrenia	0.00073	0.00086	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—schizophrenia	0.000729	0.00086	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000729	0.000859	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCB1—schizophrenia	0.000726	0.000855	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPY—schizophrenia	0.000711	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOTCH4—schizophrenia	0.000711	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ATP2A2—schizophrenia	0.000711	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1B—schizophrenia	0.000686	0.000809	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OXT—schizophrenia	0.000686	0.000809	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—schizophrenia	0.000662	0.000781	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1A—schizophrenia	0.00066	0.000778	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPS—schizophrenia	0.00065	0.000767	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MPC2—schizophrenia	0.000647	0.000762	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD1—schizophrenia	0.000638	0.000752	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2C—schizophrenia	0.000638	0.000752	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—schizophrenia	0.000621	0.000731	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD3—schizophrenia	0.000618	0.000728	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000603	0.00071	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCH2—schizophrenia	0.000601	0.000708	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD4—schizophrenia	0.0006	0.000707	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOA1—schizophrenia	0.000573	0.000675	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR1—schizophrenia	0.000573	0.000675	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NDST3—schizophrenia	0.000565	0.000666	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR7—schizophrenia	0.000559	0.000658	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD2—schizophrenia	0.000559	0.000658	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC27A5—schizophrenia	0.000536	0.000631	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACSL6—schizophrenia	0.000536	0.000631	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRL—schizophrenia	0.000528	0.000622	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000524	0.000617	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DAO—schizophrenia	0.000511	0.000602	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—S100B—schizophrenia	0.000492	0.000579	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PNP—schizophrenia	0.00049	0.000577	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ERBB4—schizophrenia	0.00047	0.000554	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NDUFV2—schizophrenia	0.000456	0.000537	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLA2G4A—schizophrenia	0.000442	0.000521	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRG1—schizophrenia	0.000434	0.000511	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MEF2C—schizophrenia	0.00043	0.000507	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIP4K2A—schizophrenia	0.000428	0.000505	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000425	0.000501	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—YWHAZ—schizophrenia	0.000416	0.00049	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ERBB3—schizophrenia	0.000407	0.000479	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—schizophrenia	0.000391	0.000461	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP26B1—schizophrenia	0.000387	0.000456	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—schizophrenia	0.000364	0.000429	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOA1—schizophrenia	0.00036	0.000424	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ESR1—schizophrenia	0.000347	0.000409	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCLM—schizophrenia	0.000345	0.000407	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TPH1—schizophrenia	0.000345	0.000407	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000326	0.000384	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRKD1—schizophrenia	0.000325	0.000383	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GSK3B—schizophrenia	0.000315	0.000371	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GAPDH—schizophrenia	0.000271	0.000319	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CLOCK—schizophrenia	0.000268	0.000316	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000268	0.000316	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000265	0.000312	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TPH2—schizophrenia	0.000262	0.000308	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNB2—schizophrenia	0.000262	0.000308	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DPYD—schizophrenia	0.000257	0.000303	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA1C—schizophrenia	0.000239	0.000282	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—schizophrenia	0.000234	0.000275	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3C2A—schizophrenia	0.000233	0.000275	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—schizophrenia	0.000212	0.00025	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SNAP25—schizophrenia	0.000209	0.000246	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2D6—schizophrenia	0.000209	0.000246	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EP300—schizophrenia	0.000207	0.000244	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP1A2—schizophrenia	0.000189	0.000223	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TH—schizophrenia	0.000186	0.00022	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COMT—schizophrenia	0.000159	0.000187	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTP1—schizophrenia	0.000158	0.000186	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOA—schizophrenia	0.000157	0.000185	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000153	0.00018	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCB1—schizophrenia	0.000149	0.000176	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—schizophrenia	0.000148	0.000175	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—schizophrenia	0.000145	0.000171	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G4A—schizophrenia	0.000145	0.000171	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—schizophrenia	0.000128	0.000151	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—schizophrenia	0.000125	0.000148	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—schizophrenia	0.000119	0.000141	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA1—schizophrenia	0.000118	0.000139	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—EP300—schizophrenia	6.8e-05	8.01e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—schizophrenia	4.11e-05	4.84e-05	CbGpPWpGaD
